Aims and Scope of Annals of Oncology
The Annals of Oncology is a peer-reviewed medical journal of oncology, published by Elsevier. It is the official journal of the European Society for Medical Oncology. The editor-in-chief is Fabrice André (Villejuif, France). Previous editors were Jean-Charles Soria, Jan Vermorken, David J. Kerr and Franco Cavalli. Less
Key Metrics
CiteScore 

47.3
Eigenfactor 

0.1 - 0.5
Impact Factor 

>= 25
Scite Index 

0.88 5-Year SI

SJR 

Q1Oncology

SNIP 

6.79
Recommended pre-submission checks
Powered by 

Topics Covered on Annals of Oncology
Annals of Oncology Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1990 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Annals of Oncology
Erratum to 'Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis': [Annals of Oncology. Volume 36, Issue 11, November 2025, Pages 1389-1399
- 7 Jan 2026
- Annals of oncology : official journal of the European Society for Medical Oncology
Editorial Board
- 1 Jan 2026
- Annals of Oncology
Table of Contents
- 1 Jan 2026
- Annals of Oncology
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).
- 30 Dec 2025
- Annals of oncology : official journal of the European Society for Medical Oncology
A tale of two trials: TAILORx and PlanB. Letter to the Editor regarding "Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/ HER2-negative breast cancer" by Chen et al.
- 20 Dec 2025
- Annals of oncology : official journal of the European Society for Medical Oncology
The Achilles heel of precision AKT-targeted therapies in advanced prostate cancer: therapeutic promise constrained by the test.
- 18 Dec 2025
- Annals of oncology : official journal of the European Society for Medical Oncology
Erratum to 'Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis': [Annals of Oncology. Volume 36, Issue 11, November 2025, Pages 1389-1399
- 7 Jan 2026
- Annals of oncology : official journal of the European Society for Medical Oncology
Editorial Board
- 1 Jan 2026
- Annals of Oncology
Table of Contents
- 1 Jan 2026
- Annals of Oncology
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).
- 30 Dec 2025
- Annals of oncology : official journal of the European Society for Medical Oncology
A tale of two trials: TAILORx and PlanB. Letter to the Editor regarding "Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/ HER2-negative breast cancer" by Chen et al.
- 20 Dec 2025
- Annals of oncology : official journal of the European Society for Medical Oncology
The Achilles heel of precision AKT-targeted therapies in advanced prostate cancer: therapeutic promise constrained by the test.
- 18 Dec 2025
- Annals of oncology : official journal of the European Society for Medical Oncology